Personal information

Pharmacology, Neuroimmunology, Neurodegeneration, Pharmaceutical Science
United States

Activities

Employment (1)

University of Nebraska Medical Center : Omaha, NE, US

2017-06-16 to present | Postdoctoral Research Associate (Pharmacology and Experimental Neuroscience)
Employment
Source: Self-asserted source
Jatin Machhi

Education and qualifications (3)

The Maharaja Sayajirao University of Baroda: Vadodara, Gujarat, IN

2013-03-25 to 2017-04-12 | Ph.D. (Department of Pharmacy )
Education
Source: Self-asserted source
Jatin Machhi

A R College of Pharmacy and G H Patel Institute of Pharmacy: Vallabh Vidhyanagar, Anand, Gujarat, IN

2010-06 to 2012-04 | M. Pharm (Pharmacology)
Education
Source: Self-asserted source
Jatin Machhi

A R College of Pharmacy and G H Patel Institute of Pharmacy: Vallabh Vidhyanagar, Anand, Gujarat, IN

2006-06 to 2010-04 | B. Pharm (Pharmacy)
Education
Source: Self-asserted source
Jatin Machhi

Funding (3)

New Tacrine-R(+)-Pramaipexole hybrids as multi-directed ligands against Alzheimer’s disease

2015-04 to 2017-04 | Salary award
University Grants Commission (New Delhi, IN)
GRANT_NUMBER:

F./2015-16/NFO-2015-17-OBC-GUJ-42831/(SA-III/Website)

Source: Self-asserted source
Jatin Machhi

Synthesis and biological evaluation of benzoannelated N-rich privileged scaffolds for Neurological disorders

2012-07 to 2016-12 | Salary award
University Grants Commission (New Delhi, IN)
GRANT_NUMBER:

F.No. 41-716/2012 (SR)

Source: Self-asserted source
Jatin Machhi

Gujarat Pharmacy Aptitude Test (GPAT) Fellowship- 2010

2010-06 to 2012-04 | Award
All India Council for Technical Education (New Delhi, Gujarat, IN)
Source: Self-asserted source
Jatin Machhi

Works (18)

The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
2020-07-21 | Journal article
Source: Self-asserted source
Jatin Machhi

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Molecular Neurodegeneration
2020-06-05 | Journal article
Source: Self-asserted source
Jatin Machhi

Immunotherapy for Parkinson's disease.

Neurobiology of disease
2020-01-21 | Journal article
Source: Self-asserted source
Jatin Machhi

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.

Theranostics
2020-01-01 | Journal article
Source: Self-asserted source
Jatin Machhi

Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.

Biomaterials
2019-12-07 | Journal article
Source: Self-asserted source
Jatin Machhi

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease.

Frontiers in cellular neuroscience
2019-09-18 | Journal article
Source: Self-asserted source
Jatin Machhi

Modulating cellular autophagy for controlled antiretroviral drug release.

Nanomedicine (London, England)
2018-08-21 | Journal article
Source: Self-asserted source
Jatin Machhi

URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease.

Journal of neuroinflammation
2018-05-05 | Journal article
Source: Self-asserted source
Jatin Machhi

Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Journal of neuroimmunology
2018-03-17 | Journal article
Source: Self-asserted source
Jatin Machhi

New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents.

Scientific reports
2018-01-26 | Journal article
Source: Self-asserted source
Jatin Machhi

Exploration of 6,7-dimethoxyquinazoline derivatives as dual acting α1- and AT1-receptor antagonists: synthesis, evaluation, pharmacophore & 3D-QSAR modeling and receptor docking studies

RSC Advances
2016 | Journal article
Source: Self-asserted source
Jatin Machhi
grade
Preferred source (of 2)‎

Dexamethasone Alters the Appetite Regulation via Induction of Hypothalamic Insulin Resistance in Rat Brain.

Molecular neurobiology
2016-11-07 | Journal article
Source: Self-asserted source
Jatin Machhi

Synthesis and Biological Evaluation of Novel Multi-target-Directed Benzazepines Against Excitotoxicity.

Molecular neurobiology
2016-10-15 | Journal article
Source: Self-asserted source
Jatin Machhi

Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.

Journal of medicinal chemistry
2016-06-13 | Journal article
Source: Self-asserted source
Jatin Machhi

Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.

Neurotoxicity research
2016-01-21 | Journal article
Source: Self-asserted source
Jatin Machhi

D3 Antagonist and Antipsychotic Potential of Some Novel Benzazepines

Journal of Pharmaceutical Sciences and Pharmacology
2015-06-01 | Journal article
Source: Self-asserted source
Jatin Machhi

Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis.

Bioorganic chemistry
2015-05-21 | Journal article
Source: Self-asserted source
Jatin Machhi

Study of antiatherosclerotic activity of polyherbal preparation using rat as an experimental animal model

International journal of pharmaceutical sciences and research
2012-10-01 | Journal issue or edition
Source: Self-asserted source
Jatin Machhi

Peer review (13 reviews for 4 publications/grants)

Review activity for BMC immunology (1)
Review activity for Journal of neuroimmune pharmacology. (10)
Review activity for Psychopharmacologia. (1)
Review activity for Respiratory medicine. (1)